Observational studies

Pharmacologic treatments

Below, we list all observational studies identified

Title Study reference Full text
Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust Bean D, medRxiv, 2020 Full text
Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial Bian H, MedRxiv, 2020 Full text
First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients Chen H, medRxiv, 2020 Full text
Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression Chen M, medRxiv, 2020 Full text
The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin Chorin E, medRxiv, 2020 Full text
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study Deng L, J Infect, 2020 Full text
Effectiveness of convalescent plasma therapy in severe COVID-19 patients Duan K, Proc Natl Acad Sci USA, 2020 Full text
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Feng Z, medRxiv, 2020 Full text
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret P, Int J Antimicrob Agents, 2020 Full text
Compassionate Use of Remdesivir for Patients with Severe Covid-18 Gautret P, Travel Med Infect Dis, 2020 Full text
Compassionate Use of Remdesivir for Patients with Severe Covid-19 Grein J, N Eng J Med, 2020 Full text
Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support Gritti G, medRxiv, 2020 Full text
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China Hu L, medRxiv, 2020 Full text
Impact of Corticosteroid Treatment in Patients with Coronavirus Lei Z, Med J Aust, 2020 Full text
Disease 2019 Leng Z, Aging Dis, 2020 Full text
Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression Liu F, Int J Infect Dise, 2020 Full text
Tocilizumab treatment in COVID-19: a single center experience Luo P, J Med Virol, 2020 Full text
An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area Meng Z, medRxiv, 2020 Full text
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection Molina JM, Med Mal Infect, 2020 Full text
Heparin therapy improving hypoxia in COVID-19 patients - a case series Negri EM, medRxiv, 2020 Full text
Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring Ramireddy A, medRxiv, 2020 Full text
Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China Shi X, J Med Virol, 2020 Full text
Clinical observations of low molecular weight heparin in relieving inflammation in COVID-19 patients: A retrospective cohort study Shi, medRxiv, 2020 Full text
No Clear Benefit to the Use of Corticosteroid as Treatment in Adult Patients with Coronavirus Disease 2019 : A Retrospective Cohort Study Wang D, medRxiv, 2020 Full text
Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China Wang Y, MedRxiv, 2020 Full text
Plasminogen improves lung lesions and hypoxemia in patients with COVID-19 Wu Y, Int J Med, 2020 Full text
Adjuvant corticosteroid therapy for critically ill patients with COVID-19 Xiaofan L, medRxiv, 2020 Full text
Effective Treatment of Severe COVID-19 Patients with Tocilizumab Xu X, ChinaXiv, 2020 Full text
Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection Yan D, medRxiv, 2020 Full text
Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2018 Ye X-T, Eur Rev Med Pharmacol Sci, 2020 Full text
Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission Zhang J, chinaXiv, 2020 Full text
Risk-adapted Treatment Strategy For COVID-19 Patients Zheng Ch, Int J Inf Dis, 2020 Full text
Interferon-a2b treatment for COVID-19 Zhou Q, medRxiv, 2020 Full text
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia Zhou W, Signal Transduct Target Ther, 2020 Full text
Arbidol Monotherapy is Superior to Lopinavir/ritonavir in Treating COVID-19 Zhu Z, J infect, 2020 Full text
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19 Zie Y, J Infect, 2020 Full text
Exosomes Derived From Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19 Sengupta V, Stem cells and developmen, 2020 Full text
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Cai Q, Engineering, 2020 Full text
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19. Sciascia S, Clinical and experimental rheumatology, 2020 Full text
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). Mercuro N, JAMA cardiology, 2020 Full text
Tocilizumab for the Treatment of Severe COVID-19 Rand A, Journal of medical virology, 2020 Full text
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy ToniatI P, Autoimmunity reviews , 2020 Full text
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study. Lian N, Clinical microbiology and infection, 2020 Full text
Full-length title: Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Million M, Médecine des voyages et maladies infectieuses, 2020 Full text
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients Klopfenstein T, Medecine et maladies infectieuses, 2020 Full text
Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE) Colaneri M, Microorganisms, 2020 Full text
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status. Antinori S, Basic research in cardiology, 2020 Full text
Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia. Capra R, European journal of internal medicine, 2020 Full text
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients Carlucci P, medRxiv, 2020 Full text
Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea Kim M, medRxiv, 2020 Full text
Arbidol/IFN-?2b Therapy for Patients With Corona Virus Disease 2019: A Retrospective Multicenter Cohort Study Xu P, Microbes and infection, 2020 Full text
Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old Gong y, Journal of medical virology, 2020 Full text
Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA): A Case Series. Barrett C, The journal of trauma and acute care surgery, 2020 Full text
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Zhu F, Lancet, 2020 Full text
Acetic acid disinfection as a potential adjunctive therapy for non-severe COVID-19. Pianta L, European archives of oto-rhino-laryngology, 2020 Full text
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Morena V, European journal of internal medicine, 2020 Full text
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study. Tremblay D, Blood, 2020 Full text
Treatment of COVID-19 Patients with Convalescent Plasma. Salazar E, The American journal of pathology, 2020 Full text
Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission-A Preliminary Report of a Retrospective Cohort Study. Zhang J, Current medical science, 2020 Full text
Hydroxychloroquine and azithromycin as a treatment of COVID-19. Fanin A, Internal and emergency medicine, 2020 Full text
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study Campochiaro C, European journal of internal medicine, 2020 Full text
Efficacy and Safety of Leflunomide for Refractory COVID-19: An Open-label Controlled Study Wang Q, medRxiv, 2020 Full text
A cohort study to evaluate the effect of combination Vitamin D, Magnesium and Vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients. Tan C W, medRxiv, 2020 Full text
Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19 Yu D, , 2020 Full text
Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 phase 2 trial Perrone F, medRxiv, 2020 Full text
Ozone therapy for patients with SARS-COV-2 pneumonia: a single-center prospective cohort study HERNANDEZ A, medRxiv, 2020 Full text
Therapeutic effectiveness of interferon-alpha2b against COVID-19: the Cuban experience Pereda R, medRxiv, 2020 Full text
[Clinical efficacy of Matrine and Sodium Chloride Injection in treatment of 40 cases of COVID-19]. Yang M, Zhongguo Zhong yao za zhi, 2020 Full text
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Cavalli G, Lancet Rheumatology, 2020 Full text
A study on clinical effect of Arbidol combined with adjuvant therapy on COVID-19. Chen W, Journal of medical virology, 2020 Full text
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China. Zuo Y, Journal of medical virology, 2020 Full text
Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas. Salazar E, medRxiv, 2020 Full text
[Clinical study of artesunate in the treatment of coronavirus disease 2019]. Lin Y, Zhonghua wei zhong bing ji jiu yi xue, 2020 Full text
Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection. Panagopoulos P, Zhonghua wei zhong bing ji jiu yi xue, 2020 Full text
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Dastan F, International immunopharmacology, 2020 Full text
The comparison of the effectiveness of lincocin ® and azitro ® in the treatment of covid-19-associated pneumonia: A prospective study. Guvenmez O, Journal of population therapeutics and clinical pharmacology, 2020 Full text
Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019. Kim JW, The Korean journal of internal medicine, 2020 Full text
Tocilizumab is associated with reduction of the risk of ICU admission and mortality in patients with SARS-CoV-2 infection Moreno Garcia E, medRxiv, 2020 Full text
ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19 Rajter JC, medRxiv, 2021 Full text
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment: a retrospective cohort study Zhou Y, medRxiv, 2022 Full text
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study. Moreno Garcia E, medRxiv, 2023 Full text
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia Temesgen Z, medRxiv, 2024 Full text
Pre exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers Bhattacharya Z, medRxiv, 2025 Full text
A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications. Oteo JA, medRxiv, 2027 Full text
Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late. Gorgolas M, medRxiv, 2029 Full text
Hospitalized COVID-19 patients treated with Convalescent Plasma in a mid-size city in the midwest Hartman W, medRxiv, 2020 Full text
Compassionate Use of Opaganib For Patients with Severe COVID-19 Kurd R, medRxiv, 2020 Full text
Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS CoV 2 MacGowan A P, medRxiv, 2020 Full text
Does Biological Therapy Protect against Severe COVID-19? Mazzucchelli R, medRxiv, 2020 Full text
Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital. Paccoud O ,Clinical infectious diseases, 2020 Full text
Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes. Price C, CHEST, 2020 Full text
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study. Vahedi E, Daru, 2020 Full text
Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case-?Controlled Study Rojas-Marte, QJM, 2020 Full text
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia. Jordan S, Clinical infectious diseases, 2020 Full text
Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals. Yang C, Frontiers in public health, 2020 Full text
Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion. Xia X, Blood, 2020 Full text
Repurposing chlorpromazine to treat COVID-19: The reCoVery study. Plaze M, L'Encephale, 2020 Full text
Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection. Khamis F, International journal of infectious diseases, 2020 Full text
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study. Giudice V, Frontiers in pharmacology, 2020 Full text
Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study. Liu J, Medicine, 2020 Full text
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia. Temesgen Z, medRxiv, 2020 Full text
Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study. Sanz Herrero F, Journal of internal medicine, 2020 Full text
Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series. Navarro-Millan I, Arthritis & rheumatology, 2020 Full text
Use of Baricitinib in Patients with Moderate and Severe COVID-19. Titanji B, Clinical infectious diseases, 2020 Full text
Short-Term Dexamethasone in Sars-CoV-2 Patients. Selvaraj V, medRxiv, 2020 Full text
Tocilizumab and steroid treatment in patients with severe Covid-19 pneumonia. Mikulska M, medRxiv, 2020 Full text
Treatment of ARDS and hyperinflammation in COVID-19 with IL-6 antagonist Tocilizumab: a tertiary care experience from Pakistan Nasir N, medRxiv, 2020 Full text
Effects of Anticoagulants and Corticosteroids therapy in patients affected by severe COVID-19 Pneumonia Sabir A M, medRxiv, 2020 Full text
The therapeutic effectiveness of Convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq Rasheed A M, medRxiv, 2020 Full text
Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection. Ferreira A, medRxiv, 2020 Full text
A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well-responding cases and rapidly-worsening cases after tocilizumab administration Hashimoto S, medRxiv, 2020 Full text
Dual-Histamine Blockade with Cetirizine - Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients Hogan R, medRxiv, 2020 Full text
Characteristics and outcomes of Acute Respiratory Distress Syndrome related to COVID-19 in Belgian and French Intensive Care Units according to antiviral strategies. The COVADIS multicenter observational study. Grimaldi D, medRxiv, 2020 Full text
Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea An M. H., medRxiv, 2020 Full text
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial) Gorial F. I., medRxiv, 2020 Full text
Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia Hess C. B., medRxiv, 2020 Full text
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Lagier JC, Travel medicine and infectious disease, 2020 Full text
INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY. Olivares-Gazca JC, Revista de investigacion clinica, 2020 Full text
Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Arshad S, International journal of infectious diseases, 2020 Full text
Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study. Yu C, Journal of medical virology, 2020 Full text
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Della-Torre E, Annals of the rheumatic diseases, 2020 Full text
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia. Erkurt M A, Transfusion and apheresis science, 2020 Full text
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series. Doi K, Critical care, 2020 Full text
An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can't Get No) Satisfaction. Lee T, International journal of infectious diseases, 2020 Full text
Tocilizumab in patients with severe COVID-19: A single-center observational analysis. Knorr JP, Journal of medical virology, 2020 Full text
Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study. Bani-Sadr F, International journal of antimicrobial agents, 2020 Full text
Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management. Suresh A, Journal of medical virology, 2020 Full text
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab. Morrison A, Journal of autoimmunity, 2020 Full text
Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis. Lecronier M, Critical care, 2020 Full text
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study Donato, M, medRxiv, 2020 Full text
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 Strohbehn, G. W, medRxiv, 2020 Full text
Remdesivir for COVID-19: match-population analysis with compassionate use of Remdesivir for severe COVID-19 Vasylyeva, O, medRxiv, 2020 Full text
SECOND WEEK METHYL-PREDNISOLONE PULSES IMPROVE PROGNOSIS IN PATIENTS WITH SEVERE CORONAVIRUS DISEASE 2019 PNEUMONIA: AN OBSERVATIONAL COMPARATIVE STUDY USING ROUTINE CARE DATA. Ruiz-Irastorza, G, medRxiv, 2020 Full text
A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial. Hu K, Virologica Sinica, 2020 Full text
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Abolghasemi H, Transfusion and apheresis science, 2020 Full text
Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study. Tomasiewicz K, Expert review of anti-infective therapy, 2020 Full text
Prophylaxis with tetracyclines in ARDS: Potential therapy for COVID-19-induced ARDS? Byrne, J. D, medRxiv, 2020
new
Full text
Resveratrol and Copper for treatment of severe COVID-19: an observational study (RESCU 002) Mittra, I, medRxiv, 2020
new
Full text
PLEXIT - Therapeutic plasma exchange (TPE) for Covid-19 cytokine release storm (CRS), a retrospective propensity matched control study kamran, s. m, medRxiv, 2020
new
Full text
Efficacy and tolerability of bevacizumab in patients with severe Covid -19 Pang, J, medRxiv, 2020
new
Full text
Use of a humanized anti-CD6 monoclonal antibody (itolizumab) in elderly patients with moderate COVID-19 Ramos-Suzarte, M, medRxiv, 2020
new
Full text
Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France Zureik, M, medRxiv, 2020
new
Full text
Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study. Eimer, J, medRxiv, 2020
new
Full text
Corticosteroid Use in Severely Hypoxemic COVID-19 Patients: An Observational Cohort Analysis of Dosing Patterns and Outcomes in the Early Phase of the Pandemic Rahman, O, medRxiv, 2020
new
Full text
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease. Satlin MJ, PloS one, 2020
new
Full text
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients. Canziani LM, Journal of autoimmunity, 2020
new
Full text
Ribavirin Therapy For Severe COVID-19: A Retrospective Cohort Study. Song T, International journal of antimicrobial agents, 2020
new
Full text
Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study. Huang M, The American journal of the medical sciences, 2020
new
Full text
Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study. Patel A, Indian journal of medical microbiology, 2020
new
Full text
Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression. Hu Z, Frontiers in public health, 2020
new
Full text
The Association of Interleukin-6 value, Interleukin inhibitors and Outcomes of Patients with COVID-19 in New York City. Maeda T, Journal of medical virology, 2020
new
Full text
[Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)]. Mareev VY, Kardiologiia, 2020
new
Full text
Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study Daniel E. Freedberg, medRxiv, 2020
new
Full text
Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019. Ong SWX, Clinical & translational immunology, 2020
new
Full text
Appropriate use of Tocilizumab in COVID-19 Infection. Keske ?, International journal of infectious diseases, 2020
new
Full text
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome. Scarsi M, Annals of the rheumatic diseases, 2020
new
Full text
The characteristics and outcomes of 681 severe cases with COVID-19 in China. Chen FF, Journal of critical care, 2020
new
Full text
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience. Hu Y, Biomedicine & pharmacotherapy, 2020
new
Full text
BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data. Wassenaar TM, Letters in applied microbiology, 2020
new
Full text
A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients. Gao G, Journal of acquired immune deficiency syndromes, 2020
new
Full text
Impact of tocilizumab administration on mortality in severe COVID-19 Tsai, A, medRxiv, 2020
new
Full text
Therapeutic effectiveness of interferon alpha 2b treatment for COVID-19 patient recovery Pereda, R, medRxiv, 2020
new
Full text

We recognize that our process might not be perfect. Please contact us if you identify an error